Both angiotensin converting enzyme inhibitors (ACEIs), which prevent the production of Ang II from Ang I, and Ang II receptor blockers (ARBs), which inhibit hormone binding to the AT1 receptor, are effective in treating hypertension as well as the accompanying cardiac fibrosis and hypertrophy. This evidence concerns the gene AGT and cardiac hypertrophy.